| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3cebdffd138188b5a19ba798ccf027c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-46 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2021-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f4dc5bff8af4e2ee3115d15f17757aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5b54a0ae03e7f46709954bb1fd10c9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab8e0d67584737b8b1ef65d771422455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75788baf1793bfea09a4369170e85280
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dd63661542dcfb7b82e79691dcee647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd0735029ec7d32b6151fdfc7033b46a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55410233d21853ebd08f6cff0d8adf72 |
| publicationDate |
2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021163273-A1 |
| titleOfInvention |
Uses of glucocorticoid receptor antagonists |
| abstract |
The present invention relates generally to the use of a glucocorticoid receptor antagonist for treating cancer, specifically solid tumors and prostate cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023043632-A1 |
| priorityDate |
2020-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |